Chemoinformaics analysis of 1,5-DIHYDROXY-2-(HYDROXYMETHYL)ANTHRACENE-9,10-DIONE
| Molecular Weight | 270.24 | nRot | 1 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 23 |
| Exact Molecular Weight | 270.053 | nRing | 3 |
| Solubility: LogS | -3.001 | nHRing | 0 |
| Solubility: LogP | 4.62 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 35.7279 |
| nHD | 3 | BPOL | 11.7681 |
| QED | 0.548 |
| Synth | 4.238 |
| Natural Product Likeliness | 2.572 |
| NR-PPAR-gamma | 0.968 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.935 |
| HIA | 0.027 |
| CACO-2 | -4.91 |
| MDCK | 0.0000116 |
| BBB | 0.035 |
| PPB | 0.996474 |
| VDSS | 1.348 |
| FU | 0.0265218 |
| CYP1A2-inh | 0.093 |
| CYP1A2-sub | 0.51 |
| CYP2c19-inh | 0.391 |
| CYP2c19-sub | 0.465 |
| CYP2c9-inh | 0.409 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.543 |
| CYP2d6-sub | 0.486 |
| CYP3a4-inh | 0.109 |
| CYP3a4-sub | 0.474 |
| CL | 11.469 |
| T12 | 0.307 |
| hERG | 0.066 |
| Ames | 0.024 |
| ROA | 0.431 |
| SkinSen | 0.7 |
| Carcinogencity | 0.08 |
| EI | 0.013 |
| Respiratory | 0.188 |
| NR-Aromatase | 0.907 |
| Antiviral | Yes |
| Prediction | 0.764848 |